Physician profile
Christopher Schneider
NPI 1114345048
$4,401.88
in general payments reported to CMS, 2019-2025
18 companies · $1,128 in 2025
The $1,128 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2021: $496 · 2022: $627 · 2023: $738 · 2024: $1,168 · 2025: $1,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,708 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,708.18 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,041.65 | 2021-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Stryker Corporation | $791.47 | 2022-2025 | Spy-Phi System, Dermacell, Molli |
| Abbvie INC. | $786.19 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $431.16 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $221.55 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acelrx Pharmaceuticals, INC. | $169.20 | 2021-2022 | |
| Sientra, INC. | $158.98 | 2021 | |
| Smith+Nephew, INC. | $142.30 | 2019-2025 | Pico |
| Horizon Therapeutics Plc | $130.21 | 2021-2022 | |
| Osiris Therapeutics INC. | $120.56 | 2019 | |
| Kerecis Limited | $78.76 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Merz North America, INC. | $77.39 | 2024-2025 | |
| Davol INC. | $73.91 | 2025 | Phasix Mesh, Arista |
| Baxter Healthcare | $71.75 | 2021-2025 | |
| Motiva USA, LLC | $46.06 | 2024-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $34.95 | 2022 | |
| W. L. Gore & Associates, INC. | $20.69 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Intuitive Surgical, INC. | $5.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.